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OBJECTIVE — The peroxisome proliferator–activated receptor-2( PPARG2) Pro12Ala
polymorphism has been associated with a higher BMI and a lower risk of type 2 diabetes in
adulthood. The association between adiposity and PPARG variants can be inﬂuenced by envi-
ronmental factors such as early growth, dietary fat, and (as recently shown) breast-feeding. The
objectives of this study were to assess 1) the inﬂuence of the PPARG2 Pro12Ala polymorphism
on adiposity markers in adolescents and 2) a possible modulating effect of breast-feeding on
these associations.
RESEARCH DESIGN AND METHODS — Data on breast-feeding duration, BMI, and
genotypes for the Pro12Ala polymorphism were available for 945 adolescents (mean age 14.7
years). The breast-feeding duration was obtained from parental records. We measured weight,
height, waist circumference, and six skinfold thicknesses.
RESULTS — No signiﬁcant associations between the Pro12Ala polymorphism and any of the
above-mentioned anthropometric parameters were found. There were signiﬁcant interactions
between the PPARG2 Pro12Ala polymorphism and breast-feeding with regard to adiposity mea-
surements(alladjustedP0.05).Indeed,inchildrenwhohadnotbeenbreast-fed,Ala12allele
carriers had higher adiposity parameters (e.g.,  BMI 1.88 kg/m
2, adjusted for age, sex, and
center,P0.007)thanPro12Proadolescents.
In contrast, in breast-fed subjects, there was
no signiﬁcant difference between Ala12 allele
carriers and Pro12Pro children in terms of ad-
iposity measurements, whatever the duration
of breast-feeding.
CONCLUSIONS — Breast-feeding ap-
pears to counter the deleterious effect of the
PPARG2 Pro12Ala polymorphism on anthro-
pometric parameters in adolescents.
Diabetes Care 33:190–196, 2010
T
he peroxisome proliferator–activated
receptor-(PPAR) transcription fac-
tor is primarily expressed in adipo-
cytes.Itisamemberofthenuclearhormone
receptor family, which inﬂuences whole-
body energy homeostasis via three main
metabolic pathways: adipocyte differentia-
tion,insulinsensitivity,andlipoproteinme-
tabolism. The PPARG gene (located on
chromosome 3) gives rise to two different
proteins, PPAR1 and PPAR2. The
PPAR2 protein is the more abundant iso-
form in adipose tissue, whereas PPAR1i s
ubiquitous. Of the several variants identi-
ﬁed in the PPARG gene, one of the most
common (minor allele frequency of 10%
inCaucasians)isthePro12Ala(rs1801282)
substitution at codon 12 in PPARG2. This
polymorphism has been shown to be asso-
ciated with reduced ability to transactivate
responsive promoters and thus with lower
PPAR2 transcriptional activity (1).
In adults, the Pro12Ala polymor-
phism has been associated with higher
BMI, waist circumference, and obesity
risk (2–4). Even though a recent meta-
analysisofgenome-wideassociationstud-
ies for BMI failed to ﬁnd any association
betweenthePro12Alapolymorphismand
childhood or adult obesity (5), another
meta-analysis showed that in selected
subgroups, such as Caucasians and obese
subjects, the Ala12 allele was associated
with greater BMI and greater insulin sen-
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
From
1INSERM, U995, Institut Fe ´de ´ratif de Recherche 114, Faculte ´d eM e ´decine, Universite ´ Droit et Sante ´
de Lille, Lille, France;
2INSERM, U744, Institut Pasteur de Lille, University Lille Nord de France, Uni-
versite ´ DroitetSante ´ deLille,Lille,France;the
3Institutfu ¨rErna ¨hrungs-undLebensmittelwissenschaften,
Humanerna ¨hrung, Rheinische Friedrich-Wilhelms, Universita ¨t Bonn, Bonn, Germany; the
4Department
ofNutritionandDietetics,HarokopioUniversity,Athens,Greece;the
5DepartmentofPaediatrics,Medical
Faculty, University of Pecs, Pecs, Hungary; the
6Department of Medical Physiology, Faculty of Medicine,
Research Group EFFECTS 262, Granada, Spain; the
7Department of Metabolism and Nutrition, Instituto
Frío-ICTAN, Spanish National Research Council, Madrid, Spain; the
8Department of Public Health,
Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium; the
9GENUD (Growth,
Exercise, Nutrition and Development) Research Group, Escuela Universitaria de Ciencias de la Salud,
UniversidaddeZaragoza,Zaragoza,Spain;the
10DepartmentofNutritionandFoodScience,Universityof
theBasqueCountry,Vitoria,Spain;the
11NationalResearchInstituteforFoodandNutrition,Rome,Italy;
and
12Centre d’Investigation Clinique CIC-9301, Centre Hospitalier & Universitaire de Lille, France.
Corresponding author: Aline Meirhaeghe, aline.meirhaeghe-hurez@pasteur-lille.fr.
Received 6 August 2009 and accepted 12 October 2009. Published ahead of print at http://care.
diabetesjournals.org on 21 October 2009. DOI: 10.2337/dc09-1459.
*AcompletelistofthemembersoftheHealthyLifestyleinEuropebyNutritioninAdolescence(HELENA)Study
Groupisavailableinanonlineappendixathttp://care.diabetesjournals.org/cgi/content/full/dc09-1459/DC1.
© 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly
cited, the use is educational and not for proﬁt, and the work is not altered. See http://creativecommons.
org/licenses/by-nc-nd/3.0/ for details.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby
marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Cardiovascular and Metabolic Risk
ORIGINAL ARTICLE
190 DIABETES CARE, VOLUME 33, NUMBER 1, JANUARY 2010 care.diabetesjournals.orgsitivity (6), suggesting that if this variant
does inﬂuence obesity predisposition, it
may do so through context-dependent
mechanisms. This ﬁnding illustrates the
importance for appropriate stratiﬁcation
of analyses by environmental or other ge-
netic factors when PPARG variants are
studied. More consistently, the Pro12Ala
polymorphismhasbeenassociatedwitha
lower risk of type 2 diabetes in a meta-
analysis of genome-wide association
studies (7).
Data in children are scarcer. In 311
Finnish children aged 7 years, the Ala12
allele was associated with a higher pon-
deral index at birth and higher waist cir-
cumference in adulthood, relative to
those for Pro12Pro subjects (8). In Greek
girls aged 3–4 years, adiposity was
higher in Ala12 allele carriers than in
Pro12Pro carriers (9).
Eriksson (10) showed that the well-
known association existing between low
birthweightandinsulinresistancelaterin
life was seen only in Pro12Pro individu-
als. Moreover, Meirhaeghe et al. (11)
showed that individuals carrying the
Ala12 allele had lower birth weight (due
to shorter gestational duration and a
higher risk of preterm birth) than
Pro12Pro subjects. However, this result
was not conﬁrmed in 5,652 individuals
from the Northern Finland Birth Cohort
of 1966 (12). Labayen et al. (13) showed
that low birth weight may program a
lower fat-free mass in adolescents carry-
ing the Ala12 allele.
Last, certain environmental factors
(such as dietary fat and physical activ-
ity)interactwiththeeffectofthePPARG
polymorphism on adiposity. Mook-
Kanamori et al. (14) showed that the
growth rate from birth to 18 months of
agewashigherinAla12Alacarriersthan
in Pro12Pro carriers when the duration
of breast-feeding was between 0 and 4
months, whereas the Pro12Ala poly-
morphism was not associated with an
early growth rate in infants breast-fed
for longer than 4 months.
The aims of the present study were to
1) assess the inﬂuence of the PPARG2
Pro12Ala polymorphism on BMI, waist
circumference, and the sum of six skin-
fold thicknesses in a sample of 945 Euro-
pean adolescents and 2) test the
modulating effect of breast-feeding on
these associations.
RESEARCH DESIGN AND
METHODS— The current report is
based on data derived from the Healthy
Lifestyle in Europe by Nutrition in Ado-
lescence (HELENA) cross-sectional
study, the aim of which was to obtain a
broad range of standardized, reliable, and
comparable nutrition- and health-related
data from a random sample of European
adolescents aged 12.5–17.5 years. Data
collection took place during 2006 and
2007 in 10 European cities. A detailed
description of the HELENA study sam-
pling has been published elsewhere (15).
All of the adolescents meeting the
general HELENA inclusion criteria and
having data for age, sex, and BMI were
considered in the ﬁnal sample (n 
3,546). To investigate biochemical assays
and genetic analyses, one-third of the co-
hort was randomly selected for blood col-
lection (resulting in a total of 1,155
subjects). Of the latter, the 945 adoles-
cents with data on the PPARG2 Pro12Ala
polymorphism and BMI and breast-
feeding information were included in the
present study.
After receiving comprehensive infor-
mation on the study’s aims and methods,
alladolescentsandtheirparentsorguard-
ians signed informed consent forms. The
study was performed according to the
ethical guidelines of the Edinburgh revi-
sion of the 1961 Declaration of Helsinki
(2000), good clinical practice, and the
legislation on clinical research in each of
the participating countries. The protocol
was approved by the investigational re-
viewboardsattheparticipatinguniversity
medical centers.
The harmonized, standardized an-
thropometric measurements were strictly
monitored. Participants were barefoot
and in underwear, and anthropometric
measurements were taken by trained re-
searchers. Weight was measured with an
electronic set of scales (Type SECA 861;
precision 0.05 kg) and height was mea-
sured in the Frankfort plane with a height
gauge (Type SECA 225; precision 1 mm).
Waistcircumferencewasmeasuredwitha
nonelastic tape (Seca 200; precision 1
mm) to the nearest 0.1 cm. Skinfold
thicknesses were measured at the left bi-
ceps, triceps, subscapular area, suprailiac
area,thigh,andcalfwithaHoltaincaliper
(precision 0.2 mm), according to Lohm-
an’s anthropometric standardization ref-
erence manual. The overall score was
calculated by summing the six skinfold
thicknesses. Mean skinfolds and circum-
ferences were calculated from three con-
secutive measurements.
Identiﬁcation of sexual maturation
(Tanner and Whitehouse stages I–V) was
assessed by a physician. Weight and
height at birth and the durations of gesta-
tion and breast-feeding were collected via
a parental questionnaire. The duration of
gestation was stratiﬁed into three catego-
ries: 35, between 35 and 40, and 40
weeks. The total duration of breast-
feeding was recoded from six categories
into four: never, 3, 3–5, and 6
months.Thedurationofexclusivebreast-
feeding (deﬁned by the World Health Or-
ganization as no liquid or solid nutrition
other than breast milk) was recoded in a
similar manner.
A uniaxial accelerometer (ActiGraph
GT1M, Pensacola, FL; http://www.
theactigraph.com) was used to assess
physical activity. Adolescents were in-
structed to place the monitor underneath
clothing, at the lower back, using an elas-
tic waistband, and to wear it for 7 consec-
utive days. They were also instructed to
wear the accelerometer during all time
awake and only to remove it during
water-based activities. At least 3 days of
recording with a minimum of 8 h regis-
tration/day was set as an inclusion crite-
rion. In this study, the time-sampling
interval(epoch)wassetat15s.Ameasure
oftotalvolumeofactivity(hereaftercalled
average physical activity) was expressed
as the sum of recorded counts per epoch
divided by total daily registered time ex-
pressed in minutes (counts per minute)
(16).
Thesocioeconomiclevelwasassessed
in terms of the maternal educational level
and was coded into four categories (ele-
mentary, lower secondary, higher sec-
ondary, or higher education).
Preparation of genomic DNA from
whole blood and genotyping
Blood samples were drawn at school after
a 10-h, overnight fast and according to a
standardized collection protocol; blood
forDNAextractionwascollectedinEDTA
K3 tubes. DNA was extracted from white
bloodcellswiththePuregenekit(Qiagen,
Courtaboeuf, France) and stored at
20°C. Genotyping of the Pro12Ala
polymorphism was performed on an Illu-
mina system using GoldenGate technol-
ogy (Illumina, San Diego, CA). The
genotyping success rate was 99.4%.
Statistical analyses
Statistical analyses were performed with
SAS software (SAS Institute, Cary, NC).
Deviation from Hardy-Weinberg equilib-
riumwastestedusingthe	
2test(1degree
of freedom). The BMI and the sum of the
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transformation. We compared groups in
terms of genotype and allele distributions
byusing	
2tests.Intergroupcomparisons
of quantitative variables were performed
using a general linear model. Reported P
values were systematically adjusted for
confounding variables. Data on anthro-
pometric phenotypes were adjusted for
age, sex, and center. Data on weight and
height at birth were adjusted for age, sex,
center, and gestational duration. Study
center was used as a surrogate estimate of
ethnicity. The presence of interaction be-
tween polymorphism and breast-feeding
for anthropometric variables was tested
with a general linear model adjusted for
age,sex,andcenter.Thethresholdforsta-
tistical signiﬁcance was set to P  0.05.
Power calculations were performed using
Quanto v1.2.4 (17).
RESULTS— Withinoursample,81.7%
of adolescents had been breast-fed (Table
1).Aquarteroftheadolescentshadﬁnished
puberty (28.3%). There were 746 (78.9%)
Pro12Pro, 187 (19.8%) Pro12Ala, and 12
(1.3%) Ala12Ala subjects (Ala12 allele fre-
quency  0.11) in the sample. This distri-
bution respected the Hardy-Weinberg
equilibrium in the HELENA study (P 
0.94) and in each center separately (data
not shown).
Table 2 presents the association be-
tween the PPARG2 Pro12Ala polymor-
phism and the neonatal characteristics
and adiposity measurements. No signiﬁ-
cant associations were found between the
Pro12Ala polymorphism and BMI, waist
circumference, and the sum of skinfolds.
Accordingly, underweight (n  61), nor-
mal-weight (n  663), overweight (n 
164),andobesechildren(n57)didnot
differ signiﬁcantly in terms of the geno-
typedistributionofthePPARG2Pro12Ala
polymorphism (P  0.82) (data not
shown). However, Ala12Ala subjects had
lower weight (P  0.03) and height (P 
0.02) at birth than subjects carrying the
Pro12 allele (Table 2), independently of
the duration of gestation. The genotype
distribution of the polymorphism did not
differ among subjects born before 35
weeks, between 35 and 40 weeks, or after
40 weeks of pregnancy (P  0.98).
After checking that the distribution
ofthePro12Alapolymorphismwassim-
ilar in all four breast-feeding categories
(never breast-fed, 3 months, 3–5
months, and 6 months) (P  0.73),
breast-feeding was introduced into the
analysis. We detected signiﬁcant inter-
actions between the Pro12Ala polymor-
phism and breast-feeding, when
considering BMI (adjusted for age, sex,
and center, P  0.004), waist circum-
ference (adjusted P  0.03), or skin-
folds (adjusted P  0.03). Indeed, in
children who had not been breast-fed
(n  173), Ala12 allele carriers had
higherBMI(1.88kg/m
2,adjustedP 
0.007) (Fig. 1A), higher waist circum-
ference (3.8 cm, adjusted P  0.02)
(Fig. 1B), and higher skinfold thick-
nesses (16.3 mm, adjusted P  0.03)
(Fig. 1C) than Pro12Pro subjects. This
association was not altered by further
adjustment for maternal educational
level, Tanner and Whitehouse stage, av-
eragephysicalactivitylevel,birthweight,or
duration of gestation (data not shown). In
contrast, in children who had been
breast-fed, there was no signiﬁcant differ-
ence in adiposity measurements between
Ala12 allele carriers and Pro12Pro sub-
jects, whatever the duration of breast-
Table 1—Descriptive characteristics of the
HELENA study sample
n Value
Neonatal data
Birth weight (kg) 914 3.33 
 0.58
Birth height (cm) 882 50.4 
 3.2
Duration of total
breast-feeding
Never breast-fed 173 (18.3)
3 months 279 (29.5)
3–5 months 237 (25.1)
6 months 256 (27.1)
Duration of
pregnancy
35 weeks 49 (5.4)
35–40 weeks 574 (63.6)
40 weeks 280 (31.0)
Clinical characteristics
Boys 434 (45.9)
Girls 511 (54.1)
Pubertal status
Tanner stage 2 12 (1.4)
Tanner stage 3/4 601 (70.3)
Tanner stage 5 242 (28.3)
Age (years) 945 14.7 
 1.4
BMI (kg/m
2) 945 21.3 
 3.8
Waist circumference
(cm) 935 72.2 
 9.3
Sum of 6 skinfolds
(mm) 887 92.0 
 41.4
Physical activity
(cpm) 638 434 
 151
Data are means 
 SD or n (%).
Table 2—Association between the PPARG2 Pro12Ala polymorphism and body composition and neonatal characteristics in the HELENA study
Pro12Pro Pro12Ala Ala12Ala P*
P*
X/Ala12 vs.
Pro12Pro
Ala12Ala vs.
X/Pro12
n 746 187 12
BMI (kg/m²) 21.3 
 3.6 21.4 
 4.3 20.2 
 2.5 0.55 0.98 0.29
Waist circumference (cm) 72.1 
 9.2 72.8 
 10.0 69.8 
 7.5 0.50 0.78 0.29
Sum of 6 skinfolds (mm) 92.2 
 41.1 92.5 
 43.5 73.2 
 24.0 0.52 0.79 0.31
Birth weight (kg) 3.33 
 0.57 3.34 
 0.57 2.90 
 1.08 0.10† 0.43† 0.03†
n 689 177 10
Birth height (cm) 50.4 
 3.1 50.4 
 2.7 47.7 
 6.1 0.07† 0.43† 0.02†
n 666 171 10
Duration of gestation
35 weeks 38 (0.78) 10 (0.20) 1 (0.02)
35–40 weeks 454 (0.79) 113 (0.20) 7 (0.01) 0.98
40 weeks 219 (0.78) 58 (0.21) 3 (0.01)
Data are means 
 SD or n (frequency). *Adjusted for age, sex. and center. †Adjusted for age, sex, center, and gestational duration.
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yielded similar results when we used the
duration of exclusive breast-feeding (data
not shown). Furthermore, there were no
signiﬁcant interactions with sex (P 
0.90),andtheassociationsweresimilarin
boys and girls (data not shown).
We performed power calculations in
the whole sample (n  945) using a dom-
inant or a recessive model, and in the
non–breast-fed children subsample (n 
173) using a dominant model only (Table
3). As an example, the whole sample had
sufﬁcient power (80%) to identify sig-
niﬁcant effect sizes of at least 0.75 kg/m
2
for BMI, 2.1 cm for waist circumference,
9.6mmforskinfoldthicknesses,140gfor
birth weight, and 0.7 cm for birth height
usingaminorallelefrequencyof0.11un-
der a dominant model.
CONCLUSIONS — In the present
study, the PPARG2 Ala12 allele was asso-
ciated with higher adiposity indexes
(BMI, waist circumference, and the sum
of skinfolds) in children who had not
been breast-fed. However, this associa-
tion was not seen in children who had
been breast-fed (even for a short period).
Our results are in agreement with
those of Mook-Kanamori et al. (14), who
showed that the Ala12 allele was associ-
ated with increased weight gain in early
infancy in non–breast-fed children (14).
We observed similar ﬁndings for BMI,
waist circumference, and skinfolds, even
later in life (i.e., adolescence). This result
supports the hypothesis whereby breast-
feeding has a beneﬁcial effect on the obe-
sity risk later in life in a genetically pre-
disposed group.
Our study illustrates an association
between an environmental factor (breast-
feeding)andthephenotypicexpressionof
agene(modulationofanthropometricpa-
rameters by PPARG) and thus suggests
that phenotypes modulated by PPARG2
polymorphisms can be inﬂuenced by
gene-environment interactions early in
life. Barker (18) has explained the impact
of pre- and postnatal nutrition later in life
by the theory of “nutritional program-
ming”:whatisbeneﬁcialinuteroanddur-
ing the postnatal period in cases of
undernutrition could become deleterious
in the event of an excessive nutritional
environment (i.e., metabolic diseases).
The exact mechanisms involved in this
type of phenomenon are still subject to
speculation; they may begin to operate
during fetal life and continue until the
early neonatal period. A recent meta-
analysis performed by the World Health
Organization, including 33 studies, con-
cluded that breast-fed individuals were
less likely to be overweight and/or obese
in childhood and adolescence (19). Some
studies but not all showed a dose-
response effect, with a more pronounced
effect associated with a long duration of
breast-feeding(20).Thereasonfortheab-
sence of a dose-response effect on the
Figure 1—A: Mean BMI as a function of the breast-feeding duration in PPARG2 Pro12Pro (f)
vs. Ala12 allele carriers ( ). **P  0.007 (adjusted for age, sex, and center). B: Mean waist
circumference as a function of breast-feeding duration in PPARG2 Pro12Pro (f) vs. Ala12 allele
carriers( ).*P0.02(adjustedforage,sex,andcenter).C:Meansumofskinfoldsasafunction
of breast-feeding duration in PPARG2 Pro12Pro (f) vs. Ala12 allele carriers ( ). *P  0.03
(adjusted for age, sex, and center).
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clear; one possible explanation is that the
programming effect of breast-feeding is
more strongly inﬂuenced by gene  nu-
trient interactions at an early age rather
than a quantitative process linked to the
duration of the exposition.
A number of mechanisms can poten-
tially explain how breast-feeding could
counterbalance the deleterious effect of the
Ala12 allele in adolescents. It has been
shown that the association between dietary
fat and BMI is inﬂuenced by PPARG2 geno-
types. Memisoglu et al. (21) found that
monounsaturated fat–rich diets were in-
versely associated with BMI in Ala12 allele
carriers, but the authors did not ﬁnd
any association in Pro12Pro women.
Similarly, Luan et al. (22) showed that
for a diet with a low polyunsaturated-
to-saturated fat ratio, Ala12 allele carri-
ers had a greater BMI than Pro12Pro
carriers. Considering that breast milk
constitutes a diet with speciﬁc fat intake
(with a higher proportion of polyunsatu-
rated fatty acids than formula milk [23]),
our results seem to be in line with those
reported by Luan et al. (22), albeit their
studywasconductedinadults.Moreover,
one potential hypothesis is that breast
milk or breast-feeding supplies factors
such as prostaglandin J2 (24), a natural
PPAR ligand. The decrease in PPAR2
transcriptional activity observed in
Ala12 allele carriers could be, therefore,
compensated for by breast milk. The
latter also contains a number of adipo-
kines. It is known that PPAR agonists
(such as the thiazolidinediones) can
downregulate leptin expression (25);
however, the presence of this com-
pound in breast and/or formula milk
has yet to be established and would re-
quire further investigation.
We also showed in the present study
that Ala12Ala subjects had a lower body
weight (430 g) and height (2.7 cm) at
birth than subjects carrying the Pro12 al-
lele,independentlyofthedurationofges-
tation. Although these results need to be
considered with caution (as they concern
only 12 homozygote children) and rep-
licated, they are in line with previous
data. Indeed, in two Irish population
samples,wehavepreviouslyshownthat
the PPARG2 Ala12 allele was associated
with lower birth weight (primarily
caused by shorter gestational duration)
(11).
The present study has certain limi-
tations. First, the duration of gestation
was coded into three categories rather
than being speciﬁed in weeks and was
obtained from questionnaires ﬁlled out
by the parents (rather than from a na-
tional health registry). Therefore, the
accuracy of the data on gestational du-
ration needs to be considered with cir-
cumspection. Second, the “being small
for gestational age” phenotype could
not be assessed. However, because the
duration of gestation did not inﬂuence
the effect of the PPARG2 polymorphism
inthepresentstudy,webelievethatthis
factordidnotbiasourresults.Likewise,
we lacked information on singleton or
multiple pregnancies, which have dif-
ferent growth patterns. Other factors
(such as parental weight status, food
preferences, or smoking status) known
to inﬂuence the effect of breast-feeding
on the subject’s subsequent BMI could
not be assessed in our study. However,
the main factors known to inﬂuence fat
masswereavailableanddidnotalterthe
observed associations when used as
confounders. Third, study center was
usedasasurrogateestimateofethnicity,
which is not ideal and may induce mis-
classiﬁcation. Last, the subgroup of
non–breast-fed children was relatively
small (n  173), which might make it
prone to identiﬁcation of false-positive
associations. However, we feel conﬁ-
dent of our data as they are in line with
the data of Mook-Kanamori et al. (14).
In summary, our results suggest that
breast-feeding can counterbalance the
deleterious impact of the PPARG2
Pro12Ala polymorphism on adiposity in
adolescents. These ﬁndings conﬁrm the
importance of taking account of gene-
environment interactions in association
studies and the possible effect of early,
diet-based prevention programs in popu-
lation subgroups. At a time when the
prevalence of obesity in children and ad-
olescents continues to increase, our re-
sults may constitute a new argument in
favor of the public health beneﬁts of
breast-feeding.
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